-The Telegraph The Supreme Court has struck down the grace marks of up to 30 per cent given to rurally posted government doctors in admissions to postgraduate medical degree courses in Odisha. Its verdict yesterday set aside an Orissa High Court order that upheld the grace marks — 10 per cent per completed year of rural service up to three years — given in the state, and therefore applies only to Odisha. But...
More »SEARCH RESULT
Take this patient to ICU-Pushpa M Bhargava
A cure for India’s health care ills is within reach provided there is political will In most developed — and many developing — countries today, a 12-year school education and universal health coverage (UHC) are the two primary responsibilities of the state. India has failed miserably on both counts. Let us look at some of the problems of medical and health care: • Fifty years ago, when there was no commercialisation of...
More »National mindset-Anupama Katakam
Apparently, people across the country, bridging class, caste and income divides, are deliberately ensuring that girls are simply not born. The child sex ratio of 914 girls per 1,000 boys is a tragic situation and a poor reflection on India’s growth and development. This is in spite of laws, schemes, relentless activism and media campaigns spanning three decades in support of the girl child. According to activists and economists, a...
More »The unwanted girl -Anupama Katakam
Census 2011 data bring into the open Maharashtra’s terrible record in sex-selective abortions. In early June, Vijaymala Patekar, a mother of four girls, haemorrhaged to death at a hospital in Parli, Beed district, Maharashtra. She was reportedly in her second trimester of pregnancy. Her family had allegedly forced her to abort the foetus when they learnt it was a girl child. Sudam Munde, the doctor who performed the procedure, fled Parli but...
More »Right to know
-The Indian Express India may not be a testing hub for Big Pharma. But informed consent must be non-negotiable Figures released by the World Health Organisation, which show that 10 Indian subjects of clinical field trials die every week, have rekindled concerns that this country has become a testing hub for Big Pharma. Ironically, the same figures deflate this persistent fear, revealing that only 1.5 per cent of global trials have been...
More »